Latest / USA Daily News / Pentagon Pulls New Testosterone Rules Just One Day After Release — Hegseth’s Military Health Plan Faces Fresh Questions

Transcript

Pentagon Pulls New Testosterone Rules Just One Day After Release — Hegseth’s Military Health Plan Faces Fresh Questions · USA Daily News

• 0:00
  Speaker 1: The Pentagon has abruptly pulled back detailed clinical guidance for
• 0:03
  Speaker 1: a new military testosterone screening program, creating fresh questions about
• 0:08
  Speaker 1: how the Defense Department plans to address hormone deficiencies among
• 0:12
  Speaker 1: service members. The guidance had appeared on a Defense Health
• 0:16
  Speaker 1: Agency website on September 2, only to disappear the following day.
• 0:20
  Speaker 1: A U.S. official said the document had been temporarily rescinded
• 0:24
  Speaker 1: so that updates could be made. While another senior advisor
• 0:28
  Speaker 1: to Defense Secretary Pete Hegseth later characterized what had been
• 0:31
  Speaker 1: posted as a draft that was accidentally released before it
• 0:35
  Speaker 1: was approved. The reversal came just weeks after Hegseth announced
• 0:39
  Speaker 1: that testosterone screening would become part of the military's regular
• 0:43
  Speaker 1: health assessments for male service members aged 30 and older.
• 0:47
  Speaker 1: The initiative was presented as part of a broader effort
• 0:50
  Speaker 1: to improve readiness, address health problems earlier, and make sure
• 0:54
  Speaker 1: troops have the physical capacity required for demanding military duties.
• 0:58
  Speaker 1: Yet the detailed guidance quickly attracted attention from physicians and
• 1:02
  Speaker 1: medical organizations that questioned whether broad population-level testosterone screening is
• 1:07
  Speaker 1: supported by enough evidence. The controversy is therefore not simply
• 1:12
  Speaker 1: about a document being removed from a website. It raises
• 1:15
  Speaker 1: questions about how military medicine should identify hormone problems how
• 1:19
  Speaker 1: aggressively those problems should be treated, and how much scientific
• 1:23
  Speaker 1: evidence should be required before a new medical policy is
• 1:26
  Speaker 1: applied across a large population of service members. The Pentagon
• 1:31
  Speaker 1: has emphasized that the program is intended to identify genuine
• 1:34
  Speaker 1: deficiencies rather than provide artificial enhancement. Hegseth has framed testosterone
• 1:40
  Speaker 1: as one of several biological factors that can influence physical performance, health,
• 1:45
  Speaker 1: and readiness. particularly as service members age or experience the
• 1:49
  Speaker 1: unusual stresses associated with military operations. Under the broader policy
• 1:54
  Speaker 1: announced in July, men aged 30 and older would undergo
• 1:58
  Speaker 1: annual testosterone screening, while younger men could receive testing voluntarily
• 2:03
  Speaker 1: or when medical circumstances warranted it. The detailed guidance that
• 2:08
  Speaker 1: was briefly posted went further by establishing pathways for questionnaires,
• 2:12
  Speaker 1: blood testing, evaluation, and possible treatment. It also contained guidance
• 2:17
  Speaker 1: concerning female service members, including questions about fatigue and disrupted
• 2:22
  Speaker 1: menstrual cycles that could point toward hormonal dysregulation or low
• 2:26
  Speaker 1: energy availability. The Pentagon has not abandoned the overall initiative. Instead,
• 2:32
  Speaker 1: officials say the interim screening guidance remains in effect while
• 2:36
  Speaker 1: a final version is prepared. That distinction is important because
• 2:40
  Speaker 1: the withdrawal of the detailed document does not mean the
• 2:43
  Speaker 1: underlying policy has disappeared. It means the department is revising
• 2:47
  Speaker 1: the clinical framework used to implement it. The reason for
• 2:51
  Speaker 1: that revision remains a major point of interest. The Pentagon
• 2:54
  Speaker 1: initially described the document as something temporarily withdrawn for updates
• 2:59
  Speaker 1: without providing a detailed explanation. Later, Hegseth advisor Tim Parlator
• 3:04
  Speaker 1: said the material was a draft that had been inadvertently
• 3:07
  Speaker 1: posted and needed additional input to make sure it reflected
• 3:11
  Speaker 1: current medical science rather than older protocols. That explanation suggests
• 3:16
  Speaker 1: the department wants to make changes before the guidance becomes
• 3:19
  Speaker 1: the definitive clinical standard. But the speed of the reversal
• 3:23
  Speaker 1: has naturally drawn scrutiny because the document was publicly presented
• 3:27
  Speaker 1: alongside an announcement that described comprehensive guidance for military medical providers.
• 3:33
  Speaker 1: The episode has created an unusual situation in which service
• 3:37
  Speaker 1: members know a major health policy is being pursued. but
• 3:40
  Speaker 1: the exact medical procedures supporting that policy remain in flux.
• 3:45
  Speaker 1: That uncertainty is particularly significant because testosterone is a hormone
• 3:49
  Speaker 1: with complex relationships to age, symptoms, physical condition, nutrition, sleep, stress, medications,
• 3:58
  Speaker 1: and underlying disease. A low measurement does not automatically mean
• 4:02
  Speaker 1: that a person has a medical disorder requiring treatment. Physicians
• 4:06
  Speaker 1: generally evaluate symptoms repeat testing, and potential underlying causes before
• 4:11
  Speaker 1: determining whether testosterone replacement is appropriate. The Pentagon's eventual final
• 4:17
  Speaker 1: guidance will therefore be closely watched by both military personnel
• 4:22
  Speaker 1: and medical professionals. The department is attempting to balance a
• 4:25
  Speaker 1: genuine concern about the health of service members with the
• 4:29
  Speaker 1: need to avoid unnecessary testing or treatment. That balance is
• 4:33
  Speaker 1: especially important in a military environment where medical decisions can
• 4:37
  Speaker 1: intersect with readiness, career concerns, deployment status, and perceptions of
• 4:43
  Speaker 1: physical capability. For now, the department has pressed pause on
• 4:47
  Speaker 1: the detailed document while keeping the interim policy alive. The
• 4:51
  Speaker 1: current controversy began in July, when Defense Secretary Pete Hegseth
• 4:55
  Speaker 1: announced that testosterone testing would become part of the routine
• 4:59
  Speaker 1: health assessments for older service members. His announcement presented the
• 5:03
  Speaker 1: policy as a readiness initiative rather than a cosmetic or
• 5:06
  Speaker 1: performance enhancement program. Hegseth argued that aging can be accompanied
• 5:11
  Speaker 1: by declining testosterone levels and that identifying deficiencies could help
• 5:16
  Speaker 1: military personnel maintain their health and effectiveness. The policy applies
• 5:21
  Speaker 1: to active duty and reserve personnel. with annual screening becoming
• 5:25
  Speaker 1: mandatory for men aged 30 and older. Service members below
• 5:29
  Speaker 1: that age can seek testing voluntarily or receive it when
• 5:32
  Speaker 1: clinicians identify symptoms or other reasons to investigate hormone levels.
• 5:37
  Speaker 1: The announcement immediately attracted attention because routine testosterone testing has
• 5:42
  Speaker 1: not traditionally been part of the standard annual health assessment
• 5:45
  Speaker 1: for the entire military population. Service members already have access
• 5:50
  Speaker 1: to medical evaluation and when medically appropriate, testosterone testing and
• 5:56
  Speaker 1: replacement therapy through military health care. What changed was the
• 6:00
  Speaker 1: decision to make hormone screening part of a broad, organized
• 6:03
  Speaker 1: military health process. Hegseth connected the initiative to the demands
• 6:08
  Speaker 1: of modern military service, arguing that troops face environments requiring
• 6:13
  Speaker 1: exceptional physical and mental readiness. The department has also pointed
• 6:17
  Speaker 1: to evidence that some military personnel— particularly those serving in
• 6:21
  Speaker 1: demanding operational communities, can experience hormonal disruption linked to prolonged stress,
• 6:28
  Speaker 1: inadequate sleep, intense physical workloads, and insufficient nutrition. Researchers have
• 6:34
  Speaker 1: studied these problems among special operations personnel and have used
• 6:38
  Speaker 1: terms such as operator syndrome to describe combinations of health
• 6:42
  Speaker 1: issues associated with sustained operational stress. Those observations form part
• 6:47
  Speaker 1: of the Pentagon's argument for taking hormone health more seriously.
• 6:51
  Speaker 1: The department's reasoning is that if demanding military conditions can
• 6:55
  Speaker 1: contribute to hormonal problems, identifying those problems earlier could potentially
• 7:00
  Speaker 1: help service members remain healthy and capable of performing their duties.
• 7:05
  Speaker 1: That argument, however, does not automatically establish that every man
• 7:09
  Speaker 1: over 30 should undergo routine testosterone testing. Medical experts have
• 7:14
  Speaker 1: raised a distinction between identifying a legitimate health concern in
• 7:18
  Speaker 1: a person with symptoms and conducting broad screening across people
• 7:22
  Speaker 1: who may not have any indication of hormone deficiency. The
• 7:25
  Speaker 1: two approaches can produce very different medical outcomes. A targeted
• 7:30
  Speaker 1: test may be used to investigate fatigue, sexual dysfunction, muscle loss,
• 7:35
  Speaker 1: low bone density, or other symptoms after a clinician considers
• 7:38
  Speaker 1: a patient's history. A universal or population-level program may identify
• 7:44
  Speaker 1: people whose hormone levels fluctuate naturally or fall into a
• 7:47
  Speaker 1: borderline range without necessarily indicating a condition that requires treatment.
• 7:53
  Speaker 1: That difference became central to the criticism surrounding the Pentagon Initiative.
• 7:58
  Speaker 1: The American Urological Association and the Endocrine Society have not
• 8:02
  Speaker 1: endorsed routine population-wide screening for low testosterone in men. Their
• 8:07
  Speaker 1: positions reflect the broader medical concern that testosterone deficiency should
• 8:11
  Speaker 1: be diagnosed through appropriate clinical evaluation rather than through a
• 8:15
  Speaker 1: single laboratory number. The Endocrine Society has emphasized the importance
• 8:20
  Speaker 1: of symptoms and consistently low measurements, while the American Urological
• 8:25
  Speaker 1: Association has similarly described diagnosis as requiring both clinical indicators
• 8:30
  Speaker 1: and properly conducted testing. These standards matter because testosterone levels
• 8:35
  Speaker 1: are not static. They can vary according to the time
• 8:38
  Speaker 1: of day, illness, sleep, nutrition, medications, body composition, and other factors.
• 8:46
  Speaker 1: A single result can therefore be misleading. A military-wide screening
• 8:50
  Speaker 1: program has to account for those variables if it is
• 8:53
  Speaker 1: going to avoid false diagnoses. The Pentagon's detailed guidance attempted
• 8:58
  Speaker 1: to establish a pathway in which screening could lead to
• 9:01
  Speaker 1: additional evaluation rather than automatically triggering treatment. That distinction is important.
• 9:07
  Speaker 1: A screening result does not necessarily mean a service member
• 9:10
  Speaker 1: would immediately receive testosterone replacement. Instead, the intended process involves
• 9:16
  Speaker 1: further assessment to determine whether a deficiency exists and whether
• 9:20
  Speaker 1: treatment is medically justified. The department has also said that
• 9:24
  Speaker 1: treatment decisions would ultimately be made by the individual in
• 9:27
  Speaker 1: consultation with medical professionals. Still, Critics remain concerned about the
• 9:33
  Speaker 1: possibility that widespread testing could increase pressure to treat borderline
• 9:37
  Speaker 1: results or create expectations that higher testosterone is inherently better.
• 9:42
  Speaker 1: That is not how medical testosterone replacement is supposed to work.
• 9:46
  Speaker 1: The strongest criticism of the Pentagon's testosterone initiative has come
• 9:50
  Speaker 1: from physicians who say the policy risks turning a legitimate
• 9:54
  Speaker 1: medical condition into a much broader screening category than the
• 9:58
  Speaker 1: evidence supports. testosterone deficiency is a real disorder and testosterone
• 10:03
  Speaker 1: replacement can be appropriate for men who have confirmed low
• 10:06
  Speaker 1: levels along with relevant symptoms and an underlying clinical reason
• 10:10
  Speaker 1: for treatment the disagreement is over whether every man in
• 10:14
  Speaker 1: a large population should routinely be screened simply because he
• 10:18
  Speaker 1: has reached a particular age Medical organizations have generally been
• 10:22
  Speaker 1: cautious about that approach. Testosterone naturally changes over the course
• 10:26
  Speaker 1: of a man's life, and levels can also vary significantly
• 10:30
  Speaker 1: from one measurement to another. Sleep deprivation, illness, stress, obesity, medications,
• 10:37
  Speaker 1: nutritional problems, and other health conditions can influence hormone levels.
• 10:42
  Speaker 1: That means a low result can be a signal that
• 10:44
  Speaker 1: requires investigation rather than an automatic prescription for hormone therapy.
• 10:49
  Speaker 1: Physicians who have criticized the Pentagon's approach worry that a
• 10:52
  Speaker 1: large screening program could identify men who have temporary or
• 10:56
  Speaker 1: borderline reductions and then place them on a treatment pathway
• 11:00
  Speaker 1: they may not actually need. Testosterone replacement is not a
• 11:04
  Speaker 1: harmless wellness supplement. It can have meaningful physiological effects and
• 11:08
  Speaker 1: treatment decisions require careful consideration of fertility, blood counts, cardiovascular issues,
• 11:15
  Speaker 1: prostate health, sleep apnea, and other medical factors. Reuters reported
• 11:20
  Speaker 1: that physicians specifically warned about potential overtreatment and emphasized that
• 11:24
  Speaker 1: routine low-testosterone screening is not endorsed by major professional organizations. Dr.
• 11:31
  Speaker 1: Jason Goldman, an internal medicine physician and former president of
• 11:35
  Speaker 1: the American College of Physicians, argued that testosterone should be
• 11:39
  Speaker 1: used when a genuine deficiency has been appropriately diagnosed rather
• 11:43
  Speaker 1: than as a general means of making people stronger or
• 11:46
  Speaker 1: more masculine. Other specialists have similarly warned that treating people
• 11:50
  Speaker 1: without a confirmed medical indication can expose them to risks
• 11:54
  Speaker 1: without delivering the promised benefits. The concerns become especially relevant
• 11:59
  Speaker 1: inside the military because service members may have reasons beyond
• 12:03
  Speaker 1: ordinary health considerations to seek or accept treatment. If hormone
• 12:08
  Speaker 1: levels are associated in the minds of troops with physical strength, stamina,
• 12:12
  Speaker 1: or readiness, Some individuals could feel pressure to pursue treatment
• 12:16
  Speaker 1: even when the medical benefit is uncertain. Conversely, troops could
• 12:20
  Speaker 1: worry that a diagnosis might affect how they are perceived
• 12:23
  Speaker 1: professionally or whether they are considered fit for certain duties.
• 12:27
  Speaker 1: The Pentagon has said that treatment is a personal choice
• 12:30
  Speaker 1: when clinicians recommend it, but the military is a hierarchical
• 12:34
  Speaker 1: institution in which medical policies can have consequences beyond an
• 12:38
  Speaker 1: ordinary doctor's office. That makes careful clinical safeguards particularly important.
• 12:44
  Speaker 1: The department also has to account for the fact that
• 12:47
  Speaker 1: testosterone deficiency can sometimes be caused by another health problem.
• 12:51
  Speaker 1: A low measurement may reflect obesity, certain medications, chronic illness,
• 12:57
  Speaker 1: inadequate nutrition, excessive training, sleep disruption, or other conditions. Simply
• 13:03
  Speaker 1: replacing testosterone without investigating the cause could potentially miss an
• 13:07
  Speaker 1: underlying problem. This is one reason doctors favor a diagnostic
• 13:11
  Speaker 1: process rather than a simplistic test-and-treat model. The final guidance
• 13:15
  Speaker 1: will therefore be judged by how well it handles repeat testing,
• 13:19
  Speaker 1: symptom assessment, evaluation of reversible causes, and informed treatment decisions.
• 13:25
  Speaker 1: The briefly published guidance reportedly included some of those safeguards,
• 13:30
  Speaker 1: which may indicate that Pentagon medical planners were attempting to
• 13:33
  Speaker 1: address the criticism. but its removal means those provisions could
• 13:37
  Speaker 1: still be revised before the final version is released. Another
• 13:41
  Speaker 1: challenge is the difference between testosterone deficiency and the popular
• 13:45
  Speaker 1: idea of low T as a general explanation for fatigue,
• 13:50
  Speaker 1: reduced energy, aging, or changes in body composition. The phrase
• 13:55
  Speaker 1: has become common in advertising and online health discussions, sometimes
• 13:59
  Speaker 1: creating the impression that testosterone is a universal solution to
• 14:03
  Speaker 1: the normal effects of aging. Doctors have pushed back against
• 14:07
  Speaker 1: that concept because aging involves many biological changes and not
• 14:11
  Speaker 1: all of them should be treated as hormone deficiency. A
• 14:14
  Speaker 1: man can feel tired without having low testosterone. He can
• 14:18
  Speaker 1: lose muscle because he is inactive, sleep poorly, gain weight,
• 14:22
  Speaker 1: or experience stress without requiring hormone replacement. The same principle
• 14:27
  Speaker 1: applies to athletic performance. Testosterone is obviously involved in muscle
• 14:32
  Speaker 1: development and other physical processes and but more hormone is
• 14:36
  Speaker 1: not automatically better for someone whose levels are already normal.
• 14:40
  Speaker 1: Although the Pentagon's public discussion of the initiative has focused
• 14:43
  Speaker 1: heavily on testosterone screening for men, the clinical guidance that
• 14:47
  Speaker 1: was temporarily removed also contained recommendations concerning female service members.
• 14:53
  Speaker 1: Those recommendations were different because women naturally produce testosterone at
• 14:57
  Speaker 1: substantially lower levels than men, and the medical questions surrounding
• 15:01
  Speaker 1: hormonal health are not identical across the sexes. Rather than
• 15:05
  Speaker 1: requiring routine testosterone blood tests for all women, the guidance
• 15:10
  Speaker 1: called for questions about symptoms such as fatigue and disrupted
• 15:13
  Speaker 1: menstrual cycles that could indicate hormonal dysregulation or problems related
• 15:18
  Speaker 1: to insufficient energy availability. This is significant because the military
• 15:22
  Speaker 1: places substantial physical demands on service members and inadequate nutrition
• 15:27
  Speaker 1: combined with intense training can affect multiple aspects of health.
• 15:32
  Speaker 1: In women, insufficient energy availability can contribute to changes in
• 15:36
  Speaker 1: menstrual function and other physiological problems. Medical specialists have long
• 15:42
  Speaker 1: recognized that athletes and highly active individuals can experience health
• 15:46
  Speaker 1: consequences when training demands consistently exceed nutritional intake. Military service
• 15:52
  Speaker 1: can create similar circumstances, particularly for personnel working under demanding
• 15:57
  Speaker 1: physical conditions. The Pentagon's approach therefore appears to recognize that
• 16:02
  Speaker 1: hormonal health is broader than testosterone alone. For female service members,
• 16:07
  Speaker 1: the emphasis was reportedly on identifying symptoms and conditions that
• 16:11
  Speaker 1: could affect health and performance rather than applying the same
• 16:14
  Speaker 1: testing model used for older men. The guidance also addressed
• 16:18
  Speaker 1: circumstances involving perimenopause and menopause, according to reporting on the document,
• 16:24
  Speaker 1: including situations where symptoms could affect a service member's duties
• 16:28
  Speaker 1: or quality of life. That reflects another challenge facing military medicine.
• 16:33
  Speaker 1: The force includes personnel at different stages of life, and
• 16:37
  Speaker 1: health policies have to account for those differences without assuming
• 16:41
  Speaker 1: that every biological change is a disease. Menopause, for example,
• 16:45
  Speaker 1: is a normal stage of aging, but symptoms can become
• 16:49
  Speaker 1: significant enough to warrant medical evaluation and treatment. A military
• 16:54
  Speaker 1: health system has an interest in making sure service members
• 16:57
  Speaker 1: can obtain appropriate care while maintaining the ability to perform
• 17:01
  Speaker 1: their duties. The inclusion of female hormonal health in the
• 17:04
  Speaker 1: broader guidance suggests that the Pentagon is attempting to develop
• 17:08
  Speaker 1: a comprehensive approach to endocrine and performance-related issues rather than
• 17:12
  Speaker 1: simply creating a men's testosterone program. Yet, it also expands
• 17:17
  Speaker 1: the scope of the policy and potentially creates additional questions
• 17:20
  Speaker 1: about how military medicine should define hormonal disorders and decide
• 17:25
  Speaker 1: when treatment is justified. The temporary withdrawal of the document
• 17:29
  Speaker 1: means those questions remain unresolved in the final policy. For
• 17:33
  Speaker 1: both men and women, the underlying challenge is to distinguish
• 17:37
  Speaker 1: normal biological variation from a medical condition requiring intervention. A
• 17:42
  Speaker 1: person may experience fatigue for many reasons. A change in
• 17:46
  Speaker 1: menstrual pattern may reflect training, nutrition, stress, illness, pregnancy, medication,
• 17:53
  Speaker 1: or another factor. A lower hormone measurement may similarly have
• 17:57
  Speaker 1: multiple explanations. A good clinical system must investigate those possibilities
• 18:03
  Speaker 1: rather than assuming that one biological marker explains everything. This
• 18:07
  Speaker 1: is especially important in the military because service members can
• 18:10
  Speaker 1: operate in extreme environments where sleep, nutrition, stress, and physical
• 18:16
  Speaker 1: workload may change dramatically. The department has cited these operational
• 18:20
  Speaker 1: conditions as part of its justification for paying greater attention
• 18:24
  Speaker 1: to hormonal health. Researchers have found that prolonged stress, intense
• 18:28
  Speaker 1: physical activity, inadequate caloric intake, and disrupted sleep can affect
• 18:34
  Speaker 1: hormone levels. but recognizing those effects does not necessarily answer
• 18:38
  Speaker 1: the question of what treatment should follow. In some cases,
• 18:42
  Speaker 1: the most appropriate response may be improved nutrition, rest, recovery,
• 18:47
  Speaker 1: or treatment of another underlying condition rather than hormone replacement.
• 18:51
  Speaker 1: That distinction is central to responsible military medicine. If the
• 18:56
  Speaker 1: final guidance encourages clinicians to search for reversible causes before
• 19:00
  Speaker 1: prescribing hormones, it could address some of the concerns raised
• 19:04
  Speaker 1: by specialists. If the policy instead encourages treatment based heavily
• 19:08
  Speaker 1: on numerical thresholds without sufficient clinical context, critics are likely
• 19:13
  Speaker 1: to intensify their objections. The department has said that the
• 19:17
  Speaker 1: final guidance will be issued after updates, but it has
• 19:21
  Speaker 1: not provided a firm public timetable. That leaves service members
• 19:25
  Speaker 1: and medical providers waiting for clarification about exactly how the
• 19:29
  Speaker 1: program will operate. The uncertainty is especially notable because the
• 19:33
  Speaker 1: detailed document was presented as a comprehensive framework before being
• 19:37
  Speaker 1: pulled back almost immediately. The Pentagon's central justification for the
• 19:42
  Speaker 1: testosterone initiative is military readiness. Defense officials argue that service
• 19:47
  Speaker 1: members operate under conditions that can place unusual stress on
• 19:51
  Speaker 1: the body and that maintaining health is essential to maintaining
• 19:54
  Speaker 1: a capable fighting force. That argument has particular relevance for
• 19:58
  Speaker 1: troops exposed to prolonged deployments demanding physical training, limited sleep,
• 20:04
  Speaker 1: psychological stress, and irregular nutrition. In those environments, Hormonal changes
• 20:10
  Speaker 1: can become one component of a much larger pattern of
• 20:13
  Speaker 1: physiological strain. Research involving special operations personnel has helped draw
• 20:18
  Speaker 1: attention to these problems. Studies have suggested that some operators
• 20:22
  Speaker 1: experience combinations of low testosterone, fatigue, sleep disruption, high stress,
• 20:28
  Speaker 1: and inadequate nutrition during demanding periods. The Pentagon has cited
• 20:33
  Speaker 1: this body of research as part of the reason it
• 20:35
  Speaker 1: wants to identify hormone deficiencies across the broader force. The
• 20:39
  Speaker 1: theory is straightforward. If a medical problem can reduce a
• 20:43
  Speaker 1: service member's health or ability to perform, identifying it early
• 20:47
  Speaker 1: could potentially improve readiness. But the transition from that observation
• 20:51
  Speaker 1: to a mandatory screening program is where the controversy begins.
• 20:56
  Speaker 1: Finding a problem in a highly specialized group does not
• 20:59
  Speaker 1: automatically establish that the same screening strategy should be applied
• 21:03
  Speaker 1: to every service member over a particular age. Special operations
• 21:07
  Speaker 1: personnel can experience conditions that differ significantly from those of
• 21:11
  Speaker 1: other military occupations. They may endure extreme physical workloads, repeated deployments,
• 21:17
  Speaker 1: prolonged sleep disruption, and other operational stresses that are not
• 21:21
  Speaker 1: representative of the entire force. A policy designed for the
• 21:25
  Speaker 1: most demanding environments may therefore need to be adapted before
• 21:29
  Speaker 1: being applied across millions of service members. The Pentagon's initiative
• 21:33
  Speaker 1: attempts to address that challenge by making screening part of
• 21:37
  Speaker 1: routine health assessments. Officials can argue that the cost of
• 21:40
  Speaker 1: identifying genuine deficiencies is justified if even a relatively small
• 21:45
  Speaker 1: number of service members benefit from early diagnosis. Critics respond
• 21:50
  Speaker 1: that widespread testing can also generate false positives, unnecessary follow-up appointments,
• 21:56
  Speaker 1: additional medical costs, and potentially inappropriate treatment. The effectiveness of
• 22:01
  Speaker 1: the program will therefore depend not only on how many
• 22:04
  Speaker 1: deficiencies it detects, but on whether those detections translate into
• 22:08
  Speaker 1: meaningful health or readiness improvements. Measuring that outcome could be complicated.
• 22:14
  Speaker 1: Military readiness is influenced by many variables, and isolating the
• 22:18
  Speaker 1: effect of testosterone treatment would require careful study. A service
• 22:23
  Speaker 1: member who receives treatment may report feeling better, but that
• 22:26
  Speaker 1: does not necessarily prove that the intervention improves deployment performance,
• 22:31
  Speaker 1: injury rates, retention, or mission effectiveness. Those are the kinds
• 22:35
  Speaker 1: of outcomes that would ultimately matter when evaluating a military
• 22:39
  Speaker 1: health policy. The department's rhetoric has sometimes placed testosterone in
• 22:44
  Speaker 1: especially direct connection with physical capability. Hegseth has described the
• 22:48
  Speaker 1: initiative in terms of restoring natural capabilities and ensuring troops
• 22:53
  Speaker 1: have the biological foundation necessary to sustain demanding operations. That
• 22:58
  Speaker 1: language reflects the military's long-standing emphasis on physical fitness and
• 23:03
  Speaker 1: combat effectiveness. But it also creates a risk of misunderstanding
• 23:07
  Speaker 1: if service members interpret testosterone as a general performance enhancer
• 23:11
  Speaker 1: rather than a treatment for confirmed deficiency. Medical professionals have
• 23:16
  Speaker 1: emphasized that more testosterone is not automatically equivalent to more strength. endurance,
• 23:21
  Speaker 1: or health. The body maintains hormone levels within a complex
• 23:25
  Speaker 1: biological system, and artificially increasing those levels can produce unwanted effects.
• 23:31
  Speaker 1: That is why treatment should be guided by medical diagnosis
• 23:35
  Speaker 1: rather than by a desire to maximize a number on
• 23:37
  Speaker 1: a laboratory report. The Pentagon therefore faces a communication challenge
• 23:42
  Speaker 1: as well as a medical one. It needs to explain
• 23:45
  Speaker 1: that screening is intended to identify health problems, not encourage
• 23:49
  Speaker 1: healthy service members to pursue hormone enhancement. It also needs
• 23:53
  Speaker 1: to reassure personnel that a medical evaluation will not automatically
• 23:57
  Speaker 1: translate into career consequences. Earlier reporting noted uncertainty about whether
• 24:02
  Speaker 1: low testosterone could affect professional status or deployment eligibility. The
• 24:07
  Speaker 1: department has not indicated that a low reading alone would
• 24:10
  Speaker 1: result in punitive action, but service members may understandably have
• 24:14
  Speaker 1: questions about how medical information could interact with military standards.
• 24:19
  Speaker 1: Clear rules will be necessary to prevent misunderstandings. The initiative
• 24:24
  Speaker 1: could potentially help service members who have genuine, previously undiagnosed deficiencies.